P51 EFFICACY AND SAFETY OF THIRD‐LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-05, Vol.7 (S2), p.38-39
Main Authors: Hanna, M., Chorazy, J., Iheanacho, I., Gorsh, B., Wang, P.F., Paka, P., Perera, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000936332.73280.e0